Epstein-Barr Virus

Cross-source consensus on Epstein-Barr Virus from 8 sources and 45 claims.

8 sources · 45 claims

Uses

How it works

Dosage & preparation

Risks & contraindications

Background

Evidence quality

Where it comes from

Other

Highlighted claims

EBV is not a living organism; it is genetic material enclosed in a protein sac with no independent metabolism. — Epstein-Barr Virus (EBV): Symptoms, Latency, and Treatment
EBV is primarily transmitted through saliva and is commonly called the kissing virus. — Epstein-Barr Virus (EBV): Symptoms, Latency, and Treatment
Mononucleosis is the acute phase of initial EBV infection. — Epstein-Barr Virus (EBV): Symptoms, Latency, and Treatment
After the acute mono phase resolves, EBV remains in the body permanently. — Epstein-Barr Virus (EBV): Symptoms, Latency, and Treatment
There is no antiviral drug that eradicates latent EBV; treatment targets returning the virus to dormancy. — Epstein-Barr Virus (EBV): Symptoms, Latency, and Treatment
EBV can only cause harm when the immune system's resistance is sufficiently lowered. — Epstein-Barr Virus (EBV): Symptoms, Latency, and Treatment
Epstein-Barr virus belongs to the herpes family and enters a latent phase in which it goes dormant inside the body rather than being eliminated by the immune system. — The 5 Things You Must Know about Epstein-Barr Virus
EBV cannot be eliminated from the body once contracted; the practical goal is permanent remission rather than eradication. — The 5 Things You Must Know about Epstein-Barr Virus
90% of the adult population has been infected with EBV. — Epstein-Barr Virus (EBV): Symptoms, Latency, and Treatment
Approximately 95% of the human population carries EBV. — The 5 Things You Must Know about Epstein-Barr Virus